Wednesday, 22. July 2026 ยท Next update: 22:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
๐Ÿ“ˆ Economy ยท Next Week

US GDP Q2 2026 Advance Estimate (BEA, July 30, 2026, 8:30 a.m. EDT) shows annualized growth above 2.5% quarter-on-quarter

Pending โœฆ AI-generated prediction Published on 22. July 2026 ยท Predicted for 30. July 2026 ยท Based on: Statistical Pattern
Probability
40%

The BEA publishes the first estimate of US GDP for Q2 2026 on July 30. The Philadelphia Fed consensus (Survey of Professional Forecasters) is 2.1% annualized, while the Atlanta Fed GDPNow model last showed 3.0% (as of approx. June 2026). This ~1 percentage point divergence signals stronger activity data than the consensus anticipates. Manifold Markets hosted a related question with implied probability of ~38โ€“42% for >2.5%. Goldman Sachs sees 2026 US growth at 2.5%. Counterforces: tariff effects and weak net exports could weigh on GDP. Our assessment: 40%, aligned with Manifold-level.

Data basis for this prediction
  • Philadelphia Fed โ€“ Survey of Professional Forecasters Q2 2026: BIP-Wachstum 2,1 % annualisiert
  • Atlanta Fed GDPNow โ€“ Stand ca. Juni 2026: 3,0 % annualisiertes BIP-Wachstum Q2 2026
  • Manifold Markets โ€“ 'Will Q2 2026 US GDP Advance Estimate exceed 2.5%?': ~38โ€“42 % implizit
  • BEA โ€“ GDP Release Calendar: Q2 2026 Advance Estimate, 30. Juli 2026, 08:30 Uhr EDT

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
Related Predictions
๐Ÿ“ˆ Economy โœฆ AI

Eli Lilly and Company (NYSE: LLY) beats Q2 2026 earnings (August 5, 2026) adjusted Non-GAAP EPS consensus of approx. $8.89 per share

Eli Lilly reports on August 5, 2026. The EPS consensus per Hudson Labs is ~$8.89 adjusted Non-GAAP EPS. Eli Lilly has beaten estimates for eight consecutive quarters, driven by explosive growth of Mounjaro (tirzepatide, diabetes/GLP-1) and Zepbound (obesity). The GLP-1 segment grows double-digits and routinely outpaces analyst estimates. No Polymarket market available; assessment based on ~85โ€“90% historical beat rate over the last 8 quarters. Risk: potential supply constraints or price pressure from IRA negotiations.

73%
Next Month ยท Predicted for 5. Aug 2026
๐Ÿ“ˆ Economy โœฆ AI

Intel Corporation (NASDAQ: INTC) beats Q2 2026 earnings (July 23, 2026, after market close) adjusted Non-GAAP EPS consensus of approx. $0.21 per share

Intel reports after market close on July 23, 2026. Alphastreet consensus is ~$0.21 adjusted Non-GAAP EPS on revenue of $14.42B. Intel has beaten estimates four consecutive quarters and is in a turnaround phase with growing AI infrastructure (Gaudi, Xeon) bookings. Analyst expectations remain conservative after a long negative streak, offering upside surprise potential. No Polymarket market available; probability based on ~60โ€“65% historical beat rate over the last 12 quarters and positive sector dynamics this quarter (GE Aerospace: +37% EPS beat on July 22, 2026).

62%
Tomorrow ยท Predicted for 23. Jul 2026
๐Ÿ“ˆ Economy โœฆ AI

Gold (XAU/USD Spot) closes above $4,200 per troy ounce on July 31, 2026

Gold closed at approx. $4,144โ€“4,152/oz on July 22, 2026 (Trading Economics) โ€” a multi-week high driven by safe-haven demand (US-Iran tensions, Strait of Hormuz) and USD weakness (EUR/USD 1.1411). Reaching $4,200 by July 31 requires ~+1.2% gain. Supporting factors: daily momentum +1.81% on July 22, WTI oil also surging (+3โ€“4%, $84โ€“88), geopolitics remaining elevated. Countering: Gold could consolidate after the rally; US GDP data (July 30) could strengthen the dollar. No specific Polymarket/Kalshi market for Gold >$4,200 by July 31 found; internal estimate based on trend extrapolation, implied volatility (XAU IV ~13%) and macro environment.

52%
Next Week ยท Predicted for 31. Jul 2026